Global H1N1 (Swine Flu) Vaccination Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS12309 | Category: Healthcare | Pages: 108 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for H1N1 (Swine Flu) Vaccination, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding H1N1 (Swine Flu) Vaccination.

The H1N1 (Swine Flu) Vaccination market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global H1N1 (Swine Flu) Vaccination market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the H1N1 (Swine Flu) Vaccination manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global H1N1 (Swine Flu) Vaccination market size in 2022 is 13290.0 million US dollars, and it is expected to be 20248.7 million US dollars by 2029, with a compound annual growth rate of 6.20% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the H1N1 (Swine Flu) Vaccination market include Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), and Mylan N.V. (U.S.). The share of the top 3 players in the H1N1 (Swine Flu) Vaccination market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of H1N1 (Swine Flu) Vaccination market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Intranasal accounted for XX% of H1N1 (Swine Flu) Vaccination market in 2022. Conjugate share of XX%.
Agripal accounted for XX% of the H1N1 (Swine Flu) Vaccination market in 2022. Fiuarix accounts for XX%.

Chapter Outline
   Chapter 1: Introduces the product overview, and global H1N1 (Swine Flu) Vaccination market status and forecast by region.
   Chapters 2-3: Segmented the global H1N1 (Swine Flu) Vaccination market by type, and application. Analyze the revenue of market segments from different perspectives.
   Chapter 4: Analysis of the competitive environment of H1N1 (Swine Flu) Vaccination market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
   Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa H1N1 (Swine Flu) Vaccination market country segmentation data.
   Chapter 10: Analyzes the main companies in the H1N1 (Swine Flu) Vaccination industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
   Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
   Chapter 12: The main points and conclusions of the report.
   Chapter 13: Concludes with an explanation of the data sources and research methods. 

Highlights-Regions

North America
   United States
   Canada
   Mexico
Europe
   Germany
   France
   UK
   Italy
   Russia
Asia Pacific
   China
   Japan
   South Korea
   India
   Southeast Asia
South America
   Brazil
   Argentina
   Colombia
MEA
   Saudi Arabia
   Egypt
   Nigeria

Player list
   Sanofi (France)
   Pfizer Inc. (U.S.)
   GSK plc (U.K.)
   Novartis AG (Switzerland)
   Mylan N.V. (U.S.)
   Baxter.(U.S.)
   AstraZeneca (U.K.)
   Johnson & Johnson Private Limited (U.S.)
   Virbac (France)
   Vetoquinol (France)
   Zoetis (U.S.)
   Novavax (U.S.).
   Zydus Group (India).
   Panacea Biotec (India).
   SINOVAC (China).
   Abbott (U.S.)
   SEQIRUS (U.S.)
   Cipla Inc (India)

Types list
   Intranasal
   Conjugate
   Attenuated Vaccines
   Inactivated Vaccines
   Intramuscular
   Toxoid

Application list
   Agripal
   Fiuarix
   Influgen
   Influvac
   Nasovac
   Vaxigrip
   Others

Table of Content

1 H1N1 (Swine Flu) Vaccination Market Overview
1.1 H1N1 (Swine Flu) Vaccination Product Overview
1.1.1 H1N1 (Swine Flu) Vaccination Product Scope
1.1.2 H1N1 (Swine Flu) Vaccination Market Status and Outlook
1.2 Global H1N1 (Swine Flu) Vaccination Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global H1N1 (Swine Flu) Vaccination Market Size by Region (2018-2029)
1.4 Global H1N1 (Swine Flu) Vaccination Historic Market Size by Region (2018-2023)
1.5 Global H1N1 (Swine Flu) Vaccination Market Size Forecast by Region (2023-2029)
1.6 Key Regions, H1N1 (Swine Flu) Vaccination Market Size (2018-2029)
1.6.1 North America H1N1 (Swine Flu) Vaccination Market Size (2018-2029)
1.6.2 Europe H1N1 (Swine Flu) Vaccination Market Size (2018-2029)
1.6.3 Asia-Pacific H1N1 (Swine Flu) Vaccination Market Size (2018-2029)
1.6.4 Latin America H1N1 (Swine Flu) Vaccination Market Size (2018-2029)
1.6.5 Middle East & Africa H1N1 (Swine Flu) Vaccination Market Size (2018-2029)
2 H1N1 (Swine Flu) Vaccination Market Overview by Type
2.3 Global H1N1 (Swine Flu) Vaccination Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global H1N1 (Swine Flu) Vaccination Historic Market Size by Type (2018-2023)
2.5 Global H1N1 (Swine Flu) Vaccination Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America H1N1 (Swine Flu) Vaccination Market Size Breakdown by Type (2018-2029)
2.6.2 Europe H1N1 (Swine Flu) Vaccination Market Size Breakdown by Type
2.6.3 Asia-Pacific H1N1 (Swine Flu) Vaccination Market Size Breakdown by Type
2.6.4 Latin America H1N1 (Swine Flu) Vaccination Market Size Breakdown by Type
2.6.5 Middle East and Africa H1N1 (Swine Flu) Vaccination Market Size Breakdown by Type
3 H1N1 (Swine Flu) Vaccination Market Overview by Application
3.3 Global H1N1 (Swine Flu) Vaccination Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global H1N1 (Swine Flu) Vaccination Historic Market Size by Application (2018-2023)
3.5 Global H1N1 (Swine Flu) Vaccination Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America H1N1 (Swine Flu) Vaccination Market Size Breakdown by Application (2018-2029)
3.6.2 Europe H1N1 (Swine Flu) Vaccination Market Size Breakdown by Application
3.6.3 Asia-Pacific H1N1 (Swine Flu) Vaccination Market Size Breakdown by Application
3.6.4 Latin America H1N1 (Swine Flu) Vaccination Market Size Breakdown by Application
3.6.5 Middle East and Africa H1N1 (Swine Flu) Vaccination Market Size Breakdown by Application
4 H1N1 (Swine Flu) Vaccination Competition Analysis by Players
4.1 Global H1N1 (Swine Flu) Vaccination Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in H1N1 (Swine Flu) Vaccination as of 2022)
4.3 Date of Key Players Enter into H1N1 (Swine Flu) Vaccination Market
4.4 Global Top Players H1N1 (Swine Flu) Vaccination Headquarters and Area Served
4.5 Key Players H1N1 (Swine Flu) Vaccination Product Solution and Service
4.6 Competitive Status
4.6.1 H1N1 (Swine Flu) Vaccination Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America H1N1 (Swine Flu) Vaccination Market Segment by Country
5.1 North America H1N1 (Swine Flu) Vaccination Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe H1N1 (Swine Flu) Vaccination Market Segment by Country
6.1 Europe H1N1 (Swine Flu) Vaccination Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific H1N1 (Swine Flu) Vaccination Market Segment by Country
7.1 Asia-Pacific H1N1 (Swine Flu) Vaccination Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America H1N1 (Swine Flu) Vaccination Market Segment by Country
8.1 Latin America H1N1 (Swine Flu) Vaccination Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa H1N1 (Swine Flu) Vaccination Market Segment by Country
9.1 Middle East & Africa H1N1 (Swine Flu) Vaccination Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  Sanofi (France)
10.1.1 Sanofi (France) Information
10.1.2 Business Overview
10.1.3 Sanofi (France) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.1.4 H1N1 (Swine Flu) Vaccination Products Offered
10.1.5 Sanofi (France) Recent Development
10.2  Pfizer Inc. (U.S.)
10.2.1 Pfizer Inc. (U.S.) Information
10.2.2 Business Overview
10.2.3 Pfizer Inc. (U.S.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.2.4 H1N1 (Swine Flu) Vaccination Products Offered
10.2.5 Pfizer Inc. (U.S.) Recent Development
10.3  GSK plc (U.K.)
10.3.1 GSK plc (U.K.) Information
10.3.2 Business Overview
10.3.3 GSK plc (U.K.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.3.4 H1N1 (Swine Flu) Vaccination Products Offered
10.3.5 GSK plc (U.K.) Recent Development
10.4  Novartis AG (Switzerland)
10.4.1 Novartis AG (Switzerland) Information
10.4.2 Business Overview
10.4.3 Novartis AG (Switzerland) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.4.4 H1N1 (Swine Flu) Vaccination Products Offered
10.4.5 Novartis AG (Switzerland) Recent Development
10.5  Mylan N.V. (U.S.)
10.5.1 Mylan N.V. (U.S.) Information
10.5.2 Business Overview
10.5.3 Mylan N.V. (U.S.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.5.4 H1N1 (Swine Flu) Vaccination Products Offered
10.5.5 Mylan N.V. (U.S.) Recent Development
10.6  Baxter.(U.S.)
10.6.1 Baxter.(U.S.) Information
10.6.2 Business Overview
10.6.3 Baxter.(U.S.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.6.4 H1N1 (Swine Flu) Vaccination Products Offered
10.6.5 Baxter.(U.S.) Recent Development
10.7  AstraZeneca (U.K.)
10.7.1 AstraZeneca (U.K.) Information
10.7.2 Business Overview
10.7.3 AstraZeneca (U.K.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.7.4 H1N1 (Swine Flu) Vaccination Products Offered
10.7.5 AstraZeneca (U.K.) Recent Development
10.8  Johnson & Johnson Private Limited (U.S.)
10.8.1 Johnson & Johnson Private Limited (U.S.) Information
10.8.2 Business Overview
10.8.3 Johnson & Johnson Private Limited (U.S.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.8.4 H1N1 (Swine Flu) Vaccination Products Offered
10.8.5 Johnson & Johnson Private Limited (U.S.) Recent Development
10.9  Virbac (France)
10.9.1 Virbac (France) Information
10.9.2 Business Overview
10.9.3 Virbac (France) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.9.4 H1N1 (Swine Flu) Vaccination Products Offered
10.9.5 Virbac (France) Recent Development
10.10  Vetoquinol (France)
10.10.1 Vetoquinol (France) Information
10.10.2 Business Overview
10.10.3 Vetoquinol (France) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.10.4 H1N1 (Swine Flu) Vaccination Products Offered
10.10.5 Vetoquinol (France) Recent Development
10.11  Zoetis (U.S.)
10.11.1 Zoetis (U.S.) Information
10.11.2 Business Overview
10.11.3 Zoetis (U.S.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.11.4 H1N1 (Swine Flu) Vaccination Products Offered
10.11.5 Zoetis (U.S.) Recent Development
10.12  Novavax (U.S.).
10.12.1 Novavax (U.S.). Information
10.12.2 Business Overview
10.12.3 Novavax (U.S.). H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.12.4 H1N1 (Swine Flu) Vaccination Products Offered
10.12.5 Novavax (U.S.). Recent Development
10.13  Zydus Group (India).
10.13.1 Zydus Group (India). Information
10.13.2 Business Overview
10.13.3 Zydus Group (India). H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.13.4 H1N1 (Swine Flu) Vaccination Products Offered
10.13.5 Zydus Group (India). Recent Development
10.14  Panacea Biotec (India).
10.14.1 Panacea Biotec (India). Information
10.14.2 Business Overview
10.14.3 Panacea Biotec (India). H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.14.4 H1N1 (Swine Flu) Vaccination Products Offered
10.14.5 Panacea Biotec (India). Recent Development
10.15  SINOVAC (China).
10.15.1 SINOVAC (China). Information
10.15.2 Business Overview
10.15.3 SINOVAC (China). H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.15.4 H1N1 (Swine Flu) Vaccination Products Offered
10.15.5 SINOVAC (China). Recent Development
10.16  Abbott (U.S.)
10.16.1 Abbott (U.S.) Information
10.16.2 Business Overview
10.16.3 Abbott (U.S.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.16.4 H1N1 (Swine Flu) Vaccination Products Offered
10.16.5 Abbott (U.S.) Recent Development
10.17  SEQIRUS (U.S.)
10.17.1 SEQIRUS (U.S.) Information
10.17.2 Business Overview
10.17.3 SEQIRUS (U.S.) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.17.4 H1N1 (Swine Flu) Vaccination Products Offered
10.17.5 SEQIRUS (U.S.) Recent Development
10.18  Cipla Inc (India)
10.18.1 Cipla Inc (India) Information
10.18.2 Business Overview
10.18.3 Cipla Inc (India) H1N1 (Swine Flu) Vaccination Revenue, Gross Margin
10.18.4 H1N1 (Swine Flu) Vaccination Products Offered
10.18.5 Cipla Inc (India) Recent Development
11 H1N1 (Swine Flu) Vaccination Market Dynamics
11.1 H1N1 (Swine Flu) Vaccination Industry Trends
11.2 H1N1 (Swine Flu) Vaccination Growth Drivers
11.3 H1N1 (Swine Flu) Vaccination Market Challenges
11.4 H1N1 (Swine Flu) Vaccination Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global H1N1 (Swine Flu) Vaccination Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?